Ofatumumab in the treatment of non-Hodgkin's lymphomas

被引：10
|
作者：
Karlin, Lionel [1 ]
Coiffier, Bertrand [1 ]
机构：
[1] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Hematol, F-69495 Pierre Benite, France
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2015年 / 15卷 / 07期
关键词：
diffuse large B-cell lymphoma; follicular lymphoma; ofatumumab; B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; REFRACTORY FOLLICULAR LYMPHOMA; ANTI-CD20; MONOCLONAL-ANTIBODY; PHASE-II TRIAL; PLUS RITUXIMAB; TARGETING BTK; CHEMOTHERAPY; MULTICENTER; COMBINATION;
D O I：
10.1517/14712598.2015.1055241
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Introduction: Ofatumumab is a second-generation humanized monoclonal antibody targeting CD20 registered for the treatment of patients with relapsing/refractory chronic lymphocytic leukemia. This review will describe the activity of ofatumumab in patients with CD20 B-cell lymphomas. Areas covered: A review of all manuscript published on ofatumumab activity in B-cell lymphomas is presented with conclusions on the future use of this antibody in these patients. Expert opinion: Ofatumumab activity is low in indolent or aggressive B-cell lymphomas. The future of this drug is challenged by new monoclonal antibodies and new targeted drugs.
引用
收藏
页码：1085 / 1091
页数：7
相关论文
共 50 条
  • [21] Hodgkin's disease and non-Hodgkin lymphomas
    Gutiérrez, EO
    REVISTA CLINICA ESPANOLA, 1999, 199 : 44 - 51
  • [22] BCG AND TREATMENT OF NON-HODGKIN LYMPHOMAS
    HOERNI, B
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1986, 2 (01): : 1 - 3
  • [23] Obinutuzumab for the treatment of non-Hodgkin lymphomas
    Hernandez, Juana
    Nielsen, Tina
    Klein, Christian
    Wenger, Michael
    NATURE, 2018, 563 (7731)
  • [24] Classification of non-Hodgkin's lymphomas
    Norton, AJ
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (04): : 641 - 652
  • [25] Progress in the non-Hodgkin's lymphomas
    Yuen, AR
    ANNALS OF ONCOLOGY, 1999, 10 : 19 - 22
  • [26] Radioimmunotherapy of non-Hodgkin's lymphomas
    Cheson, Bruce D.
    CURRENT DRUG TARGETS, 2006, 7 (10) : 1293 - 1300
  • [27] Non-Hodgkin's lymphomas - Preface
    Linch, DC
    BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (04): : R9 - R9
  • [28] Non-Hodgkin's lymphomas in breast
    Gursan, N.
    Ozmen, S.
    Sener, E.
    VIRCHOWS ARCHIV, 2015, 467 : S61 - S61
  • [29] Management of non-Hodgkin's lymphomas
    Mounter, PJ
    Lennard, AL
    POSTGRADUATE MEDICAL JOURNAL, 1999, 75 (879) : 2 - 6
  • [30] Epratuzumab in non-Hodgkin's lymphomas
    Furman R.R.
    Coleman M.
    Leonard J.P.
    Current Treatment Options in Oncology, 2004, 5 (4) : 283 - 288
12345